Diabetes technology

Real-World Performance of First- Versus Second-Generation Automated Insulin Delivery Systems on a Pediatric Population With Type 1 Diabetes: A One-Year Observational Study

J Diabetes Sci TechnolPublished Retrospective observational cohort study

Authors' conclusion

Both systems showed sustained and successful glycemic outcomes in the first year of use. However, AHCL users achieved tighter glycemic targets, without an increase of hypoglycemia risk. Improved usability of the device may also have contributed to optimal glycemic outcomes by ensuring better continuity of the automatic mode activation.

Study context

Population
Children and adolescents with T1D aged 7 to 18 years switching to automated insulin delivery (AID) therapy; 55.6% females
Participants
54 children
Exposure
Second-generation AID vs first-generation AID
Outcome
Real-world performance of AID systems: CGM metrics, system settings, insulin requirements and anthropometric parameters
Follow-up
Start period, six months, 12 months
Methodological detailssingle-centre, one-year follow-up, Data retrospectively gathered at start period, six months and 12 months
  • Single-centre
  • One-year follow-up
  • Data retrospectively gathered at start period, six months and 12 months

Main finding

As reported in the abstract

CGM metrics · Two weeks after starting automatic mode
  • Advanced hybrid closed-loop (AHCL) vs hybrid closed-loop (HCL): P = 0.016
  • AHCL vs HCL: P = 0.022
  • AHCL vs HCL: P = 0.047
  • AHCL vs HCL: P = 0.012

Observational data: associations, not effects.

Further findings

OutcomeP value
Mean sensor glucose and GMI · 12 monthsAHCL vs HCL · mean sensor glucose; better with AHCLP = 0.021
Mean sensor glucose and GMI · 12 monthsAHCL vs HCL · GMI; better with AHCLP = 0.027
Time in automatic mode and shifts to manual mode · every time pointP < 0.001
  • Time in automatic mode and shifts to manual mode: longer time in automatic mode and fewer shifts to manual mode with second-generation AID

Mean sensor glucose and GMI · 12 months

Both HCL and AHCL users achieved the recommended clinical targets over the entire study period

Original publication

Real-World Performance of First- Versus Second-Generation Automated Insulin Delivery Systems on a Pediatric Population With Type 1 Diabetes: A One-Year Observational Study. J Diabetes Sci Technol. Published 11 July 2023. doi:10.1177/19322968231185115

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.